Keros Therapeutics (KROS) Cash from Operations (2019 - 2025)
Keros Therapeutics (KROS) posted Cash from Operations of 27292000.0 for Q4 2025, down 940.01% on a QoQ basis from 3249000.0 in Q3 2025, and up 40.68% year-over-year from 19400073.17 in Q4 2024.
Keros Therapeutics (KROS) Cash from Operations (2019 - 2025) Analysis & Trends
Keros Therapeutics' Cash from Operations history runs 7 years deep, the most recent figure standing at 27292000.0 for Q4 2025.
- Quarterly Cash from Operations rose 40.68% year-over-year to 27292000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 107505000.0 (up 166.83% YoY) and the FY2025 annual result came in at 107505000.0, up 166.83% from the prior year.
- Cash from Operations was 27292000.0 for Q4 2025 at Keros Therapeutics, down from 3249000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 161171000.0 in Q1 2025 and bottomed at 46008000.0 in Q4 2024.
- A 5-year average of 15504100.0 and a median of 25030500.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 2299.09% — and 2025, when it jumped 461.69%.
- Keros Therapeutics' Cash from Operations stood at 19565000.0 in 2021, then declined by 9.6% to 21443000.0 in 2022, then decreased by 18.73% to 25459000.0 in 2023, then tumbled by 80.71% to 46008000.0 in 2024, then jumped by 40.68% to 27292000.0 in 2025.
- Business Quant data shows KROS's Cash from Operations at 27292000.0 in Q4 2025, 3249000.0 in Q3 2025, and 29623000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - | -27.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.29 Mn |
| Dec 31, 2025 | -27.29 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | -29.62 Mn |
| Jun 30, 2025 | -29.62 Mn |
| Mar 31, 2025 | 161.17 Mn |
| Mar 31, 2025 | 161.17 Mn |
| Dec 31, 2024 | -46.01 Mn |
| Dec 31, 2024 | -46.01 Mn |
| Sep 30, 2024 | -30.50 Mn |
| Sep 30, 2024 | -30.50 Mn |
| Jun 30, 2024 | -39.80 Mn |
| Jun 30, 2024 | -39.80 Mn |
| Mar 31, 2024 | -44.56 Mn |
| Mar 31, 2024 | -44.56 Mn |
| Dec 31, 2023 | -25.46 Mn |
| Dec 31, 2023 | -25.46 Mn |
| Sep 30, 2023 | -33.98 Mn |
| Sep 30, 2023 | -33.98 Mn |